A study of patients with multi-vessel disease presenting with acute myocardial infarction undergoing primary percutaneous coronary intervention (PPCI) including a prospective registry of all PPCI patients and a pilot study in a subset of patients with multi-vessel coronary disease randomised to a strategy of early multi-vessel revascularisation or infarct related artery revascularisation only

niversity Hospitals of Leicester NHS Trust (UK)0 个研究点目标入组 1,250 人开始时间: 2011年2月24日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Suspected or proven acute myocardial infarction
•2. Significant ST elevation on electrocardiogram (ECG)
•3. Less than 12 hours of symptom onset
•4. Scheduled for primary percutaneous coronary intervention (PCI) for clinical reasons
•5. Provision of verbal assent followed by written informed consent
•1. Suspected or proven acute myocardial infarction
•2. Significant ST elevation on ECG
•3. Less than 12 hours of symptom onset
•4. Scheduled for Primary PCI for clinical reasons
•5. Provision of verbal assent followed by written informed consent
•6. Multivessel coronary disease detected at time of angiography

•There are no formal exclusion criteria for the CVLPRIT registry for patients that meet the inclusion criteria.
•1. Any contraindication to PPCI or multi-vessel PPCI
•2. Less than 18 years age
•3. Clear indication for or contraindication to multivessel PPCI, according to operator judgement and the reasons will be documented
•4. Severe kidney impairment

发起方

niversity Hospitals of Leicester NHS Trust (UK)